Fuhrman Alan
SEC CIK 1303521 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TYRA | Tyra Biosciences, Inc. | CFO | 37.1K | $152.0K | — | 9 | 2023-09-15 | 2026-09-15 |
Most active insiders at TYRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MORE ROBERT J | Dir | — | $5.25M |
| 2 | Bensen Daniel | Chief Discovery Off | — | $4.81M |
| 3 | KAPLAN GILLA | Dir | — | $528.5K |
| 4 | Verjee Rehan | Dir | $20.0K | — |
| 5 | Rueb Yuliya | VP, Fin (PAO) | — | — |
| 6 | Warner Douglas J | Chief Medical Off | — | — |
| 7 | Ashar Bhavesh | COO | — | — |
| 8 | Harris Todd | Pres, CEO, Dir | — | — |
| 9 | Fuhrman Alan | CFO | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-17 19:25 | 2026-09-15 | TYRA | Tyra Biosciences, Inc. | Fuhrman Alan | CFO | A - Grant | $9.13 | +951 | 37.1K | +3% | +$8,682 | |
| D | 2026-05-07 16:30 | 2026-05-05 | TYRA | Tyra Biosciences, Inc. | Fuhrman Alan | CFO | A - Grant | $0.00 | +20.0K | 36.2K | +124% | $0 |
| 2026-03-17 | 2026-03-13 | TYRA | Tyra Biosciences, Inc. | Fuhrman Alan | CFO | A - Grant | $9.13 | +1,376 | 16.2K | +9% | +$12.6K | |
| 2025-09-17 | 2025-09-15 | TYRA | Tyra Biosciences, Inc. | Fuhrman Alan | CFO | A - Grant | $9.13 | +701 | 14.8K | +5% | +$6,400 | |
| 2025-03-18 | 2025-03-14 | TYRA | Tyra Biosciences, Inc. | Fuhrman Alan | CFO | A - Grant | $9.78 | +1,238 | 14.1K | +10% | +$12.1K | |
| 2024-11-01 | 2024-10-30 | TYRA | Tyra Biosciences, Inc. | Fuhrman Alan | CFO | P - Purchase | $16.00 | +9,500 | 12.8K | +284% | +$152.0K | |
| 2024-09-17 | 2024-09-13 | TYRA | Tyra Biosciences, Inc. | Fuhrman Alan | CFO | A - Grant | $12.48 | +954 | 3,349 | +40% | +$11.9K | |
| 2024-03-19 | 2024-03-15 | TYRA | Tyra Biosciences, Inc. | Fuhrman Alan | CFO | A - Grant | $12.48 | +932 | 2,395 | +64% | +$11.6K | |
| 2023-09-19 | 2023-09-15 | TYRA | Tyra Biosciences, Inc. | Fuhrman Alan | CFO | A - Grant | $12.50 | +1,463 | 1,463 | New | +$18.3K |
Purchase Sale Sale after option exercise All abbreviations